|
Afinitor 10 mg
tbl (blis. Al/PA/Al/PVC) 1x30 ks
|
|
HLL01EG02 - Everolimus
|
TBL |
Novartis Europharm Limited (IRL) |
Novartis Slovakia s.r.o. (Divízia Pharma) (SVK)
|
79398 |
- |
Nie
|
zobraziť
|
|
Afinitor 5 mg
tbl (blis. Al/PA/Al/PVC) 1x30 ks
|
|
HLL01EG02 - Everolimus
|
TBL |
Novartis Europharm Limited (IRL) |
Novartis Slovakia s.r.o. (Divízia Pharma) (SVK)
|
79395 |
- |
Nie
|
zobraziť
|
|
Alecensa 150 mg tvrdé kapsuly
cps dur (blis.PA/Al/PVC/Al) 4x56 ks (224 ks)
|
|
HLL01ED03 - Alektinib
|
CPS DUR |
Roche Registration GmbH (DEU) |
Roche Slovensko, s.r.o. (SVK)
|
3040C |
10/2019 |
Áno
|
zobraziť
|
|
ALUNBRIG 180 mg
tbl flm (blis.Aclar/Al) 1x28 ks
|
|
HLL01ED04 - Brigatinib
|
TBL FLM |
Takeda Pharma A/S (DNK) |
Takeda Pharmaceuticals Czech Republic s.r.o. (CZE)
|
9790C |
9/2019 |
Áno
|
zobraziť
|
|
ALUNBRIG 30 mg
tbl flm (blis.Aclar/Al) 1x28 ks
|
|
HLL01ED04 - Brigatinib
|
TBL FLM |
Takeda Pharma A/S (DNK) |
Takeda Pharmaceuticals Czech Republic s.r.o. (CZE)
|
0643D |
9/2019 |
Áno
|
zobraziť
|
|
ALUNBRIG 90 mg + 180 mg
tbl flm 7x90 mg + 21x180 mg (blis.Aclar/Al - úvod.bal.), 1x1 set
|
|
HLL01ED04 - Brigatinib
|
TBL FLM |
Takeda Pharma A/S (DNK) |
Takeda Pharmaceuticals Czech Republic s.r.o. (CZE)
|
0644D |
9/2019 |
Áno
|
zobraziť
|
|
ALUNBRIG 90 mg
tbl flm (blis.Aclar/Al) 1x28 ks
|
|
HLL01ED04 - Brigatinib
|
TBL FLM |
Takeda Pharma A/S (DNK) |
Takeda Pharmaceuticals Czech Republic s.r.o. (CZE)
|
9788C |
9/2019 |
Áno
|
zobraziť
|
|
Bosulif 100 mg
tbl flm (blis.PVC/PCTFE/PVC) 1x28 ks
|
|
HLL01EA04 - Bozutinib
|
TBL FLM |
Pfizer Europe MA EEIG (BEL) |
Pfizer Export B.V. (NLD)
|
4972A |
12/2017 |
Nie
|
zobraziť
|
|
Bosulif 500 mg
tbl flm (blis.PVC/PCTFE/PVC) 1x28 ks
|
|
HLL01EA04 - Bozutinib
|
TBL FLM |
Pfizer Europe MA EEIG (BEL) |
Pfizer Export B.V. (NLD)
|
4974A |
8/2015 |
Nie
|
zobraziť
|
|
Braftovi 50 mg tvrdé kapsuly
cps dur (blis.PA/Al/PVC/Al) 1x28 ks
|
|
HLL01EC03 - Enkorafenib
|
CPS DUR |
Pierre Fabre Médicament (FRA) |
PIERRE FABRE MEDICAMENT s.r.o. - org. Zložka (SVK)
|
9512C |
7/2019 |
Áno
|
zobraziť
|
|
Braftovi 75 mg tvrdé kapsuly
cps dur (blis.PA/Al/PVC/Al) 1x42 ks
|
|
HLL01EC03 - Enkorafenib
|
CPS DUR |
Pierre Fabre Médicament (FRA) |
PIERRE FABRE MEDICAMENT s.r.o. - org. Zložka (SVK)
|
9513C |
7/2019 |
Áno
|
zobraziť
|
|
CABOMETYX 20 mg filmom obalené tablety
tbl flm (fľ.HDPE) 1x30 ks
|
|
HLL01EX07 - Kabozantinib
|
TBL FLM |
Ipsen Pharma (FRA) |
Ipsen Pharma (FRA)
|
1412C |
10/2020 |
Nie
|
zobraziť
|
|
CABOMETYX 40 mg filmom obalené tablety
tbl flm (fľ.HDPE) 1x30 ks
|
|
HLL01EX07 - Kabozantinib
|
TBL FLM |
Ipsen Pharma (FRA) |
Ipsen Pharma (FRA)
|
1414C |
3/2020 |
Nie
|
zobraziť
|
|
CABOMETYX 60 mg filmom obalené tablety
tbl flm (fľ.HDPE) 1x30 ks
|
|
HLL01EX07 - Kabozantinib
|
TBL FLM |
Ipsen Pharma (FRA) |
Ipsen Pharma (FRA)
|
1416C |
3/2019 |
Nie
|
zobraziť
|
|
Calquence 100 mg filmom obalené tablety
tbl flm (blis.Al/Al) 1x60 ks
|
|
HLL01EL02 - Akalabrutinib
|
TBL FLM |
AstraZeneca AB (SWE) |
AstraZeneca AB (SWE)
|
3188E |
7/2023 |
Áno
|
zobraziť
|
|
Calquence 100 mg tvrdé kapsuly
cps dur (blis.Al/Al) 1x60 ks
|
|
HLL01EL02 - Akalabrutinib
|
CPS DUR |
AstraZeneca AB (SWE) |
-
|
5865D |
10/2022 |
Nie
|
zobraziť
|
|
Caprelsa 100 mg filmom obalené tablety
tbl flm (blis.PVC/PVDC/Al) 1x30 ks
|
|
HLL01EX04 - Vandetanib
|
TBL FLM |
Sanofi B.V. (NLD) |
Swixx Biopharma s. r. o. (SVK)
|
32668 |
8/2016 |
Áno
|
zobraziť
|
|
Caprelsa 300 mg filmom obalené tablety
tbl flm (blis.PVC/PVDC/Al) 1x30 ks
|
|
HLL01EX04 - Vandetanib
|
TBL FLM |
Sanofi B.V. (NLD) |
Swixx Biopharma s. r. o. (SVK)
|
32669 |
4/2016 |
Áno
|
zobraziť
|
|
COMETRIQ 20 mg, COMETRIQ 80 mg tvrdé kapsuly
cps dur 84x20 mg + 28x80 mg, 1x1 set
|
|
HLL01EX07 - Kabozantinib
|
CPS DUR |
Ipsen Pharma (FRA) |
Ipsen Pharma (FRA)
|
1303B |
4/2015 |
Áno
|
zobraziť
|
|
Cotellic 20 mg
tbl flm (blis.PVC/PVDC) 3x21 ks (63 ks)
|
|
HLL01EE02 - Kobimetinib
|
TBL FLM |
Roche Registration GmbH (DEU) |
Roche Slovensko, s.r.o. (SVK)
|
7209B |
- |
Áno
|
zobraziť
|
|
Daruph 55 mg
tbl flm (blis.OPA/Al/PVC/Al) 1x60 ks
|
|
HLL01EA02 - Dazatinib
|
TBL FLM |
Zentiva, k.s. (CZE) |
Zentiva International a.s. (SVK)
|
2452E |
9/2023 |
Áno
|
zobraziť
|
|
Daruph 79 mg
tbl flm (blis.OPA/Al/PVC/Al) 1x30 ks
|
|
HLL01EA02 - Dazatinib
|
TBL FLM |
Zentiva, k.s. (CZE) |
Zentiva International a.s. (SVK)
|
2456E |
9/2023 |
Áno
|
zobraziť
|
|
Dasatinib Krka 100 mg
tbl flm (blis.OPA/Al/PVC/Al) 1x30 ks
|
|
HLL01EA02 - Dazatinib
|
TBL FLM |
KRKA, d.d., Novo Mesto (SVN) |
KRKA, tovarna zdravil, d.d. (SVN)
|
2559D |
4/2023 |
Áno
|
zobraziť
|
|
Dasatinib Krka 70 mg
tbl flm (blis.OPA/Al/PVC/Al) 1x60 ks
|
|
HLL01EA02 - Dazatinib
|
TBL FLM |
KRKA, d.d., Novo Mesto (SVN) |
KRKA, tovarna zdravil, d.d. (SVN)
|
2556D |
3/2020 |
Áno
|
zobraziť
|
|
Dasatinib Sandoz 100 mg
tbl flm (blis.Al/OPA/Al/PVC-jednotliv.dáv.) 30x1 ks
|
|
HLL01EA02 - Dazatinib
|
TBL FLM |
Sandoz Pharmaceuticals d.d. (SVN) |
SANDOZ d.d. - organizačná zložka (SVK)
|
9829C |
11/2023 |
Áno
|
zobraziť
|
|
Dasatinib Sandoz 70 mg
tbl flm (blis.Al/OPA/Al/PVC-jednotliv.dáv.) 60x1 ks
|
|
HLL01EA02 - Dazatinib
|
TBL FLM |
Sandoz Pharmaceuticals d.d. (SVN) |
SANDOZ d.d. - organizačná zložka (SVK)
|
9827C |
11/2023 |
Áno
|
zobraziť
|
|
Dasatinib Teva 100 mg
tbl flm (blis.OPA/Al/PVC/Al-jednotliv.dáv.) 30x1 ks
|
|
HLL01EA02 - Dazatinib
|
TBL FLM |
Teva B.V. (NLD) |
TEVA Pharmaceuticals Slovakia s.r.o. (SVK)
|
0636D |
12/2022 |
Áno
|
zobraziť
|
|
Dasatinib Teva 70 mg
tbl flm (blis.OPA/Al/PVC/Al-jednotliv.dáv.) 60x1 ks
|
|
HLL01EA02 - Dazatinib
|
TBL FLM |
Teva B.V. (NLD) |
TEVA Pharmaceuticals Slovakia s.r.o. (SVK)
|
0633D |
12/2022 |
Áno
|
zobraziť
|
|
Dasatinib Zentiva 100 mg
tbl flm (blis.OPA/Al/PVC/Al) 1x30 ks
|
|
HLL01EA02 - Dazatinib
|
TBL FLM |
Zentiva, k.s. (CZE) |
Zentiva International a.s. (SVK)
|
2532D |
12/2022 |
Áno
|
zobraziť
|
|
Dasatinib Zentiva 70 mg
tbl flm (blis.OPA/Al/PVC/Al) 1x60 ks
|
|
HLL01EA02 - Dazatinib
|
TBL FLM |
Zentiva, k.s. (CZE) |
Zentiva International a.s. (SVK)
|
2529D |
1/2023 |
Áno
|
zobraziť
|
|
Erlotinib Sandoz 100 mg
tbl flm (blis.Al/OPA/Al/PVC) 1x30 ks
|
|
HLL01EB02 - Erlotinib
|
TBL FLM |
Sandoz Pharmaceuticals d.d. (SVN) |
SANDOZ d.d. - organizačná zložka (SVK)
|
7458C |
4/2020 |
Áno
|
zobraziť
|
|
Erlotinib Sandoz 150 mg
tbl flm (blis.Al/OPA/Al/PVC) 1x30 ks
|
|
HLL01EB02 - Erlotinib
|
TBL FLM |
Sandoz Pharmaceuticals d.d. (SVN) |
SANDOZ d.d. - organizačná zložka (SVK)
|
7459C |
4/2020 |
Áno
|
zobraziť
|
|
Erlotinib STADA 100 mg
tbl flm (blis.Al/OPA/Al/PVC) 1x30 ks
|
|
HLL01EB02 - Erlotinib
|
TBL FLM |
STADA Pharma (DEU) |
STADA PHARMA Slovakia, s. r. o. (SVK)
|
4688C |
3/2020 |
Áno
|
zobraziť
|
|
Erlotinib STADA 150 mg
tbl flm (blis.Al/OPA/Al/PVC) 1x30 ks
|
|
HLL01EB02 - Erlotinib
|
TBL FLM |
STADA Pharma (DEU) |
STADA PHARMA Slovakia, s. r. o. (SVK)
|
4691C |
3/2020 |
Áno
|
zobraziť
|
|
Erlotinib Teva B.V. 100 mg
tbl flm (blis. Al/PVC) 1x30 ks
|
|
HLL01EB02 - Erlotinib
|
TBL FLM |
Teva B.V. (NLD) |
TEVA Pharmaceuticals Slovakia s.r.o. (SVK)
|
8439C |
4/2020 |
Áno
|
zobraziť
|
|
Erlotinib Teva B.V. 150 mg
tbl flm (blis. Al/PVC) 1x30 ks
|
|
HLL01EB02 - Erlotinib
|
TBL FLM |
Teva B.V. (NLD) |
TEVA Pharmaceuticals Slovakia s.r.o. (SVK)
|
8440C |
4/2020 |
Áno
|
zobraziť
|
|
Erlotinib Vipharm 100 mg
tbl flm (blis.OPA/Al/PVC/Al) 1x30 ks
|
|
HLL01EB02 - Erlotinib
|
TBL FLM |
Vipharm S.A. (POL) |
Vipharm S.A. (POL)
|
2274D |
4/2020 |
Áno
|
zobraziť
|
|
Erlotinib Vipharm 150 mg
tbl flm (blis.OPA/Al/PVC/Al) 1x30 ks
|
|
HLL01EB02 - Erlotinib
|
TBL FLM |
Vipharm S.A. (POL) |
Vipharm S.A. (POL)
|
2275D |
4/2020 |
Áno
|
zobraziť
|
|
Erlotinib Zentiva 150 mg
tbl flm (blis.OPA/Al/PVC/Al) 1x30 ks
|
|
HLL01EB02 - Erlotinib
|
TBL FLM |
Zentiva, k.s. (CZE) |
-
|
4271D |
12/2020 |
Áno
|
zobraziť
|
|
Everolimus Accord 10 mg
tbl (blis.OPA/Al/PVC/Al) 1x30 ks
|
|
HLL01EG02 - Everolimus
|
TBL |
Accord Healthcare Polska Sp. z o.o. (POL) |
ProFound Bratislava, s.r.o. (SVK)
|
4143E |
2/2024 |
Áno
|
zobraziť
|
|
Everolimus Accord 5 mg
tbl (blis.OPA/Al/PVC/Al) 1x30 ks
|
|
HLL01EG02 - Everolimus
|
TBL |
Accord Healthcare Polska Sp. z o.o. (POL) |
ProFound Bratislava, s.r.o. (SVK)
|
4140E |
2/2024 |
Áno
|
zobraziť
|
|
Everolimus Krka 10 mg
tbl (blis.OPA/Al/PVC/Al) 1x30 ks
|
|
HLL01EG02 - Everolimus
|
TBL |
KRKA, d.d., Novo Mesto (SVN) |
KRKA, tovarna zdravil, d.d. (SVN)
|
8510C |
3/2022 |
Áno
|
zobraziť
|
|
Everolimus Krka 5 mg
tbl (blis.OPA/Al/PVC/Al) 1x30 ks
|
|
HLL01EG02 - Everolimus
|
TBL |
KRKA, d.d., Novo Mesto (SVN) |
KRKA, tovarna zdravil, d.d. (SVN)
|
8507C |
3/2022 |
Áno
|
zobraziť
|
|
Everolimus Sandoz 10 mg
tbl (blis.Al/PA/Al/PVC) 1x30 ks
|
|
HLL01EG02 - Everolimus
|
TBL |
Sandoz Pharmaceuticals d.d. (SVN) |
SANDOZ d.d. - organizačná zložka (SVK)
|
1204D |
3/2022 |
Áno
|
zobraziť
|
|
Everolimus Sandoz 5 mg
tbl (blis.Al/PA/Al/PVC) 1x30 ks
|
|
HLL01EG02 - Everolimus
|
TBL |
Sandoz Pharmaceuticals d.d. (SVN) |
SANDOZ d.d. - organizačná zložka (SVK)
|
1198D |
3/2022 |
Áno
|
zobraziť
|
|
EVEROLIMUS STADA 10 mg
tbl (blis.OPA/Al/PVC/Al-jednotliv.bal.) 1x30 ks
|
|
HLL01EG02 - Everolimus
|
TBL |
STADA Pharma (DEU) |
STADA PHARMA Slovakia, s. r. o. (SVK)
|
0990D |
3/2022 |
Áno
|
zobraziť
|
|
EVEROLIMUS STADA 5 mg
tbl (blis.OPA/Al/PVC/Al-jednotliv.bal.) 1x30 ks
|
|
HLL01EG02 - Everolimus
|
TBL |
STADA Pharma (DEU) |
STADA PHARMA Slovakia, s. r. o. (SVK)
|
0987D |
4/2022 |
Áno
|
zobraziť
|
|
Everolimus Teva 5 mg
tbl (blis.OPA/Al/PVC/Al-jednotliv.bal.) 30x1 ks
|
|
HLL01EG02 - Everolimus
|
TBL |
TEVA Pharmaceuticals Slovakia s.r.o. (SVK) |
TEVA Pharmaceuticals Slovakia s.r.o. (SVK)
|
4325C |
4/2022 |
Nie
|
zobraziť
|
|
Everolimus Vipharm 10 mg
tbl (blis.Al/Al) 1x30 ks
|
|
HLL01EG02 - Everolimus
|
TBL |
Vipharm S.A. (POL) |
Vipharm S.A. (POL)
|
2212D |
8/2022 |
Áno
|
zobraziť
|
|
Everolimus Vipharm 5 mg
tbl (blis.Al/Al) 1x30 ks
|
|
HLL01EG02 - Everolimus
|
TBL |
Vipharm S.A. (POL) |
Vipharm S.A. (POL)
|
2209D |
8/2022 |
Áno
|
zobraziť
|